Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan 17;422(1-2):341-8.
doi: 10.1016/j.ijpharm.2011.10.020. Epub 2011 Oct 13.

Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings

Affiliations

Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings

Jie Shen et al. Int J Pharm. .

Erratum in

  • Int J Pharm. 2012 Jun 15;429(1-2):168

Abstract

Dexamethasone loaded poly(lactic-co-glycolic acid) (PLGA) microsphere/PVA hydrogel composites have been investigated as an outer drug-eluting coating for implantable devices such as glucose sensors to counter negative tissue responses to implants. The objective of this study was to develop a discriminatory, accelerated in vitro release testing method for this drug-eluting coating using United States Pharmacopeia (USP) apparatus 4. Polymer degradation and drug release kinetics were investigated under "real-time" and accelerated conditions (i.e. extreme pH, hydro-alcoholic solutions and elevated temperatures). Compared to "real-time" conditions, the initial burst and lag phases were similar using hydro-alcoholic solutions and extreme pH conditions, while the secondary apparent zero-order release phase was slightly accelerated. Elevated temperatures resulted in a significant acceleration of dexamethasone release. The accelerated release data were able to predict "real-time" release when applying the Arrhenius equation. Microsphere batches with faster and slower release profiles were investigated under "real-time" and elevated temperature (60°C) conditions to determine the discriminatory ability of the method. The results demonstrated both the feasibility and the discriminatory ability of this USP apparatus 4 method for in vitro release testing of drug loaded PLGA microsphere/PVA hydrogel composites. This method may be appropriate for similar drug/device combination products and drug delivery systems.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Dexamethasone release from formulation 503H composite coatings at 37°C in PBS (pH 7.4 and pH 2.4), using USP apparatus 4: (△) pH 7.4, and (○) pH 2.4. (Mean±std dev; n=3).
Fig. 2
Fig. 2
SEM micrographs of formulation 503H (PLGA microspheres and composites) after exposure to different release conditions (PBS pH 7.4 and pH 2.4) at 37°C over time: (A, B) initial; (C, D) pH 7.4, day 10; (E, F) pH 7.4, day 20; (G, H) pH 2.4, day 10; (I, J) pH 2.4, day 20. Symbols: white arrows - “insideout” degrading microspheres; and black arrows - “outside-in” degrading PLGA microspheres. Top row, microspheres alone, pH 7.4. Second row, composites, pH 7.4. Third row, microspheres alone, pH 2.4. Fourth row, composites, pH 2.4. Scale bar: 20 µm.
Fig. 3
Fig. 3
Dexamethasone release from formulation 503H composite coatings in PBS (pH 7.4) and PBS (pH 7.4) containing 10 % (v/v) ethanol at 37°C, using USP apparatus 4: (△) PBS (pH 7.4), and (●) 10 % ethanol (v/v). (Mean±std dev; n=3).
Fig. 4
Fig. 4
SEM micrographs of formulation 503H (PLGA microspheres and composites) after exposure to PBS (pH 7.4) containing 10 % (v/v) ethanol at 37°C over time: (A, B) day 1 and (C, D) day 10; Symbols: white arrows - “inside-out” degrading PLGA microspheres, grey arrows - porous hydrogel matrix. Top row, microspheres alone. Second row, composites. Scale bar: 20 µm.
Fig. 5
Fig. 5
Dexamethasone release from formulation 503H composite coatings in PBS (pH 7.4) at elevated temperatures, using USP apparatus 4: (△) 37°C, (●) 45°C, (×) 50°C, (○) 53°C and (▲) 60°C. (Mean±std dev; n=3).
Fig. 6
Fig. 6
SEM micrographs of formulation 503H composites after exposure to PBS (pH 7.4): (A) 1 day, at 45°C; (B) 7 days, at 45°C; (C) 1 day, at 50°C; (D) 5 days, at 50°C; (E) 3 days, at 53°C; (F) 4 hours, at 60°C; Symbol: white arrow - “inside-out” degrading PLGA microspheres. Scale bar: 20 µm.
Fig. 7
Fig. 7
Arrhenius plot of the calculated zero-order rate constants of dexamethasone release from formulation 503H composite coatings as a function of temperature at 45°C, 50°C, 55°C and 60°C (■). Rate constants at 37°C for predicted and experimental values are shown as a cross (×) and an open square (□), respectively.
Fig. 8
Fig. 8
Dexamethasone release from composite coatings (formulations DLG2A, DLG3A 503H and DLG4A) in PBS (pH 7.4) at 37°C, using USP apparatus 4: (×) DLG2A, (●) DLG3A, (△) 503H and (▲) DLG4A. (Mean±std dev; n=3).
Fig. 9
Fig. 9
Dexamethasone release from composite coatings (formulations 503H, DLG2A, DLG3A and DLG4A) at 60°C in PBS (pH 7.4), using USP apparatus 4: (×) DLG2A, (●) DLG3A, (△) 503H and (■) DLG4A. (Mean±std dev; n=3).

Similar articles

Cited by

References

    1. Alexis F. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)] Polym. Int. 2005;54:36–46.
    1. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin. Immunol. 2008;20:86–100. - PMC - PubMed
    1. Bhardwaj U, Burgess DJ. A novel USP apparatus 4 based release testing method for dispersed systems. Int. J. Pharm. 2010;388:287–294. - PubMed
    1. Bhardwaj U, Papadimitrakopoulos F, Burgess DJ. A review of the development of a vehicle for localized and controlled drug delivery for implantable biosensors. J. Diabetes Sci. Technol. 2008;2:1016–1029. - PMC - PubMed
    1. Bhardwaj U, Sura R, Papadimitrakopoulos F, Burgess DJ. Controlling acute inflammation with fast releasing dexamethasone-PLGA microsphere/pva hydrogel composites for implantable devices. J. Diabetes Sci. Technol. 2007;1:8–17. - PMC - PubMed

Publication types